<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00868556</url>
  </required_header>
  <id_info>
    <org_study_id>V81708</org_study_id>
    <secondary_id>Merck Grant IISP 36047</secondary_id>
    <nct_id>NCT00868556</nct_id>
  </id_info>
  <brief_title>fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease?</brief_title>
  <official_title>fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 2 visit research study for patients with or without a diagnosis of migraine.
      Participants will be administered informed consent, have a medical history taken and a
      physical examination performed, and complete 3 questionnaires at the first visit. The
      participants will have a functional MRI performed after completion of Visit 1. Study stipends
      will be given for each completed research visit.

      The purpose of this study is to potentially identify risk factors and/or biomarkers (which
      are differences in the brain structures)by comparing the brain MRI scans of migraine
      sufferers to brain scans of control persons to attempt to identify migraine progression using
      the functional MRI scans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At Visit 1, patients in 3 diagnostic arms,(consisting of subjects with episodic migraine,
      chronic daily migraine or non-migraineurs/controls), of 11 subjects each, will be consented
      and then have a physical exam, medical history and current medication use documented. Each of
      these enrolled subjects will have a PRIME MD assessment administered, and will complete the
      MIDAS and ASC-12 questionnaires.

      At Visit 2 these same subjects will have an fMRI performed.

      Subjects will be greater than age 18, have the appropriate diagnoses, be able to be consented
      and not be pregnant or have an inability to have the fMRI performed (have implanted metal
      devices, have severe claustrophobia).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>assess anatomical changes with emphasis in iron deposition in brainstem structures of migraineurs and controls</measure>
    <time_frame>within a month after consent is obtained</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlate outcomes with headache surrogates (frequency, time since onset and age)</measure>
    <time_frame>within one month after enrollment</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">33</enrollment>
  <condition>Episodic Migraine</condition>
  <condition>Chronic Daily Migraine</condition>
  <arm_group>
    <arm_group_label>1 episodic migraine sufferers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>2 chronic migraine sufferers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>3 non migraine sufferers (controls)</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        11 episodic migraine sufferers, 11 chronic migraine sufferers, 11 non-migraine sufferers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult episodic, chronic or non-migraine sufferers able to consent

        Exclusion Criteria:

          -  contraindication to MRI such as severe claustrophobia and implanted devices such as
             neurostimulators, pacemakers, aneurysm clips, etc

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stewart J Tepper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wolff HG. Headache and Other Head Pain, New York: Oxford Univ Press; 1963</citation>
  </reference>
  <reference>
    <citation>Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001 Jul-Aug;41(7):629-37.</citation>
    <PMID>11554950</PMID>
  </reference>
  <reference>
    <citation>Siberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994 Jan;34(1):1-7. Review.</citation>
    <PMID>8132434</PMID>
  </reference>
  <reference>
    <citation>Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996 Oct;47(4):871-5.</citation>
    <PMID>8857711</PMID>
  </reference>
  <reference>
    <citation>Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Field testing alternative criteria for chronic migraine. Cephalalgia. 2006 Apr;26(4):477-82.</citation>
    <PMID>16556250</PMID>
  </reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2009</study_first_submitted>
  <study_first_submitted_qc>March 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2009</study_first_posted>
  <last_update_submitted>January 4, 2010</last_update_submitted>
  <last_update_submitted_qc>January 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Stewart Tepper MD, PI</name_title>
    <organization>Cleveland Clinic Foundation</organization>
  </responsible_party>
  <keyword>fMRI scans</keyword>
  <keyword>episodic migraine sufferers</keyword>
  <keyword>chronic migraine sufferers</keyword>
  <keyword>non migraine sufferers (controls)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Siderosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

